摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

β-benzyl-L-aspartic acid amide trifluoroacetate | 92762-94-2

中文名称
——
中文别名
——
英文名称
β-benzyl-L-aspartic acid amide trifluoroacetate
英文别名
H-Asp(OBzl)-NH2 trifluoroacetate;TFA*Asp(OBzl)-NH2;benzyl (3S)-3,4-diamino-4-oxobutanoate;2,2,2-trifluoroacetic acid
β-benzyl-L-aspartic acid amide trifluoroacetate化学式
CAS
92762-94-2
化学式
C2HF3O2*C11H14N2O3
mdl
——
分子量
336.268
InChiKey
GWYINGZAJZJMRO-FVGYRXGTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.57
  • 重原子数:
    23.0
  • 可旋转键数:
    5.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    132.71
  • 氢给体数:
    3.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    参考文献:
    名称:
    胆囊收缩素的一些部分修饰的逆反类似物的合成和生物学活性。
    摘要:
    描述了胆囊收缩素的C末端八肽或七肽的一些部分修饰的逆反类似物的合成。这些类似物(其中C-末端羧酰胺被缺失或未被缺失)是通过还原母体分子中的一个或几个肽键而获得的。所有这些化合物都能够抑制标记的CCK-8与大鼠胰腺腺泡和豚鼠脑膜的结合,并以各种效力刺激从大鼠胰腺腺泡释放的淀粉酶。这些衍生物中的一些仅在淀粉酶释放时再现CCK的生物学反应的一部分。
    DOI:
    10.1021/jm00130a018
  • 作为产物:
    参考文献:
    名称:
    Synthesis, anti-inflammatory and antimicrobial activities of new 1,2,4-oxadiazoles peptidomimetics
    摘要:
    A new series of 1,2,4-oxadizoles 6a-g have been synthesised in good yields using the peptide synthesis strategy. The prepared compounds were tested for anti-inflammatory and antimicrobial activities. The anti-inflammatory activities were determined in the rat paw oedema induced by carrageenin. Compounds 6a, c, f and g (i.v.) significantly inhibited the rat paw oedema induced by carrageenin depending upon the dose employed. The compounds were also evaluated for their in vitro antimicrobial activity. Some compounds were found to have significant activity against Gram positive and Gram negative microorganisms. (C) 2000 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(00)00099-9
点击查看最新优质反应信息

文献信息

  • Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists
    作者:R. Gonzalez-Muniz、F. Bergeron、I. Marseigne、C. Durieux、Bernard P. Roques
    DOI:10.1021/jm00174a016
    日期:1990.12
    (Z) and of the N-terminal tripeptide moiety in the antagonist properties of the cholecystokinin CCK8 analogue Boc-[Nle28,Orn(Z)31]CCK27-33 (Marseigne et al. J. Med. Chem. 1988, 31, 966.) were studied with the following derivatives: Boc-[Nle28,Orn(X)31]CCK27-33, Boc[Nle28,Orn(X)31]CCK27-32, Boc-[Orn(X)31]CCK30-33, and Boc-[Orn(X)31]CCK30-32 (X = Z, Boc, H). These derivatives, the synthesis of eight of
    羰基(Z)和N端三肽部分在胆囊收缩素CCK8类似物Boc- [Nle28,Orn(Z)31] CCK27-33的拮抗特性中的各自作用(Marseigne et al.J.Med。 Chem。1988,31,966.)研究了以下衍生物:Boc- [Nle28,Orn(X)31] CCK27-33,Boc [Nle28,Orn(X)31] CCK27-32,Boc- [Orn( X)31] CCK30-33和Boc- [Orn(X)31] CCK30-32(X = Z,Boc,H)。测试了这些衍生物的合成,此处报道了其中的八种衍生物的合成,以测试它们抑制[3H] pCCK8与豚鼠胰腺和脑膜结合的能力,以及刺激豚鼠胰腺痤疮淀粉酶释放的能力。Z衍生物均不产生淀粉酶分泌,但它们竞争性拮抗CCK8诱导的刺激。N末端三肽和/或Phe-NH2(33)残基的缺失在识别外周受体和这些肽的活性中不发挥关键作
  • 2-Amino-4-pyrrolidinothieno[2,3-<i>d</i>]pyrimidine-6-carboxylic Acid as an<i>N</i>-Terminal Surrogate in Amino Acid and Peptide Analogues
    作者:George Varvounis、Paul Cordopatis、Evangelos E. Bissyris、Dimitris Belekos、Vassiliki Magafa、Petros G. Tsoungas
    DOI:10.1055/s-2005-918426
    日期:——
    (ATPC) is an unnatural amino acid with promise in applications as a building block for the synthesis of peptidomimetics. ATPC was obtained from both 3a and 3b thienopyrimidines by hydrolysis and hydrogenolysis, respectively. The synthesis of eleven ATPC-amino acids and two ATPC-peptides is described. ATPC is incorporated as N-terminal moiety in solution or solid-phase peptide synthesis using Boc or
    2-Amino-4-pyrrolidinothieno[2,3-d]pyrimidine-6-carboxy acid (4) (ATPC) 是一种非天然氨基酸,有望作为合成肽模拟物的构件。ATPC 分别通过解和解从 3a 和 3b 噻吩嘧啶中获得。描述了十一种ATPC-氨基酸和两种ATPC-肽的合成。使用 Boc 或 Fmoc 方法将 ATPC 作为 N 端部分引入溶液或固相肽合成中,而无需保护 ATPC 基。
  • Peptidomimetic organocatalysts: efficient Michael addition of ketones onto nitroolefins with very low catalyst loading
    作者:Srivari Chandrasekhar、Chintakunta Praveen Kumar、Togapur Pavan Kumar、Kothapalli Haribabu、Bharatam Jagadeesh、Jerripothula K. Lakshmi、Prathama S. Mainkar
    DOI:10.1039/c4ra04165h
    日期:——
    The syntheses of two novel peptidomimetic triazole-based organocatalysts that work for the asymmetric conjugate addition of cyclohexanone to nitroolefins are described. The catalysts worked with very low loading (0.5 mol%) in the absence of any additives to provide high diastereo- and enantio-selectivities.
    描述了两种新型的拟肽三唑类有机催化剂的合成,这些催化剂可用于将环己酮不对称地加成到硝基烃中。在不存在任何添加剂的情况下,催化剂以非常低的负载量(0.5mol%)工作,以提供高的非对映选择性和对映选择性。
  • Structure-activity relationships of C-terminal tri- and tetrapeptide fragments that inhibit gastrin activity
    作者:Jean Martinez、Jean Pierre Bali、Richard Magous、Janine Laur、Marie Francoise Lignon、Christian Briet、Dino Nisato、Bertrand Castro
    DOI:10.1021/jm00381a002
    日期:1985.3
    A series of tri- and tetrapeptide derivatives, analogues of the gastrin C-terminal region with no phenylalanine residue, were synthesized. These peptides were tested for their ability to inhibit gastrin-stimulated acid secretion in vivo as well as binding of [125I]-(Nle11)-HG-13 to gastric mucosal cell receptors in vitro. Most of the peptides tested exhibited gastrin antagonist activity in vivo and in vitro. Most active derivatives were 20-30 times more potent than the well-known gastrin antagonist derivatives proglumide and benzotript and had 20-200 times more binding affinity. The smallest fragment exhibiting antagonist activity was the tripeptide Boc-L-tryptophyl-L-methionyl-L-aspartic acid amide.
  • Synthesis of structural analogs of the 13–16 fragment of gastrin, and their effects on gastric secretion
    作者:Yu. M. Taskaeva、G. A. Korshunova、L. S. Vasilevskaya、Yu. P. Shvachkin
    DOI:10.1007/bf00766860
    日期:1990.2
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸